Pathfinder Wealth Consulting’s Abbott ABT Stock Holding History

Pathfinder Wealth Consulting’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,302	Closed	-$442K	–	3
2026 Q1	$442K	Buy	4,302 +88	+2%	+$9.94K	0.29%	85
2025 Q4	$528K	Buy	+4,214	New	+$537K	0.33%	69

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Pathfinder Wealth Consulting's ABT Position: Q2 2026 in Review

Pathfinder Wealth Consulting sold out of Abbott (ABT) in Q2 2026, closing a stake of 4,302 shares — an estimated $442K sold.

Pathfinder Wealth Consulting first reported a position in ABT in Q4 2025 and held it in 2 quarters. The position peaked at $528K in Q4 2025. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Pathfinder Wealth Consulting reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Pathfinder Wealth Consulting sold 4,302 Abbott shares in Q2 2026, an estimated $442K.
Pathfinder Wealth Consulting first reported a position in Abbott in Q4 2025 and held it in 2 quarters.
Pathfinder Wealth Consulting's Abbott position peaked at $528K in Q4 2025.
2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Pathfinder Wealth Consulting's 13F filing for Q2 2026.